Experimental Medicine Award

About this scheme

Key information

Career level
Established independent researcher
Clinician
Research area
Clinical trials
Biomarker research
Preliminary submission
Final submission
Committee review
Funding period
up to 5 years
Funding amount
typically £1 – £5 million*
The Experimental Medicine Award provides funding for studies addressing large, high impact translational questions in association with a clinical trial.
  • The scheme accepts investigator-led studies for highly ambitious translational research conducted in association with a clinical trial with the objective of optimising treatment and maximising patient benefit.
  • Translational research considered within the scheme will typically be associated with, or lead to, one or more clinical trials within the lifetime of the award, where it can be clearly demonstrated that the findings would directly impact on the trial(s).
  • Typically these trials may be funded as part of an Experimental Medicine Award application where they have biological primary endpoints, or through Late Phase Trial Awards where they have clinical primary endpoints.
  • Applicants must be from a UK university, research institution, clinical centre or clinical trials unit (CTU).
  • Applications must be developed with the involvement of an experienced CTU.

Funding support is provided for:

  • Salaries for researchers and technical staff
  • Running expenses
  • Equipment

*Guide costs are typically £1 - £5 million for the duration of the award. Larger amounts may be considered with appropriate justification. Please contact the Clinical Research Funding team before submitting your application if you would like to apply for a larger amount.

How to apply to this scheme

​Application process overview

Applications for this scheme are considered twice a year and most applications require you to submit an outline first.

20th September 2017

Outline application deadline

November 2017

Clinical Research Committee meeting (decision on whether a full application is invited)

January 2018

Full application deadline

April 2018

Expert Review Panel meeting

May 2018

Clinical Research Committee meeting (final decision)

The next outline application deadline after September 2017 will be in March 2018.

An outline application can be omitted if you are applying for endorsement only or if you are applying for a costed amendment or extension. In these circumstances, the following dates apply:

7th December 2017

Full application deadline

March 2018

Expert Review Panel meeting

May 2018

Clinical Research Committee meeting (final decision)

Before you begin your application

  • You must provide the Clinical Research Funding team with a two page proposal describing your study. After we have checked that your proposal is within remit for an Experimental Medicine Award, you’ll be able to begin your application.

  • You must read the application guidelines before starting your application, even if you have applied for funding with us before.

  • You must read the costs guidance (PDF) to understand what we will and will not fund.

Yes. Academically-sponsored studies in receipt of educational grants or free drugs from the pharmaceutical industry can be submitted for CRUK endorsement.

Industry-sponsored trials cannot be reviewed under this scheme.

Under exceptional circumstances, applications for extensions to funding are accepted under this scheme. Please contact the Clinical Research Funding team to discuss the need for an extension, and for access to an extension application form.

Requests for no-cost extensions can be made by submitting the no-cost extension request form to the Clinical Research Funding team.

Yes. Amendments must be reviewed by the Committee where there is a significant change to the study design, sample size or study drug. There are two routes for review of amendments:

  • Review at a Committee meeting: this applies where additional funding is being requested. An amendment application must be submitted to the advertised deadline for that funding round and will be reviewed at a Committee meeting.
  • Out of Committee Review: this applies where no funding is being requested for the amendment. An amendment application must be submitted, which will be reviewed outside of the Committee meeting. A faster review is usually possible for this route.

In both cases, please contact the Clinical Research Funding team for guidance and for access to an amendment application form. 

Our priorities are set out in our Clinical Research Statement of Intent.

Applications are assessed by the Experimental Medicine Expert Review Panel. Final funding recommendations are made by the Clinical Research Committee (CRC).

​You must contact a funding manager to discuss you proposal before starting your application.

Applications from Wales

caroline daltonDr Caroline Dalton

Senior Research Funding Manager

clinicalresearch@cancer.org.uk

Tel: 020 3469 8860

 

 

Applications from London

Ewan Hughes McInnesMr Ewan Hughes McInnes

Research Funding Manager

clinicalresearch@cancer.org.uk

Tel: 020 3469 6532

 

 

Applications from Northern England and Scotland

Dr Caroline Glover, Research Funding Manager

Ms Caroline Glover

Research Funding Manager

clinicalresearch@cancer.org.uk

Tel: 0203 469 8934

 

 

Applications from Southern England, the Midlands and Northern Ireland

Ms Kirsty Tunna

Research Funding Manager

clinicalresearch@cancer.org.uk

Tel: 0203 469 5800

Useful resources

Designing a clinical trial or study is a complex task, with many practical and regulatory hurdles to cross. Our Funding Managers share 13 resources to help you find advice and navigate the complexities of your study design and application.